- Home
- XNCR vs CSTM Comparison
XNCR vs CSTM Comparison
Compare XNCR & CSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- CSTM
- Stock Information
- Founded
- XNCR 1997
- CSTM 2010
- Country
- XNCR United States
- CSTM France
- Employees
- XNCR N/A
- CSTM N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- CSTM Metal Fabrications
- Sector
- XNCR Health Care
- CSTM Industrials
- Exchange
- XNCR Nasdaq
- CSTM Nasdaq
- Market Cap
- XNCR 1.7B
- CSTM 1.7B
- IPO Year
- XNCR 2013
- CSTM 2013
- Fundamental
- Price
- XNCR $20.45
- CSTM $10.62
- Analyst Decision
- XNCR Strong Buy
- CSTM Strong Buy
- Analyst Count
- XNCR 9
- CSTM 5
- Target Price
- XNCR $36.33
- CSTM $21.00
- AVG Volume (30 Days)
- XNCR 766.2K
- CSTM 1.1M
- Earning Date
- XNCR 02-25-2025
- CSTM 02-19-2025
- Dividend Yield
- XNCR N/A
- CSTM N/A
- EPS Growth
- XNCR N/A
- CSTM N/A
- EPS
- XNCR N/A
- CSTM 0.75
- Revenue
- XNCR $85,164,000.00
- CSTM $7,559,669,861.00
- Revenue This Year
- XNCR N/A
- CSTM N/A
- Revenue Next Year
- XNCR $80.86
- CSTM $4.62
- P/E Ratio
- XNCR N/A
- CSTM $14.36
- Revenue Growth
- XNCR N/A
- CSTM N/A
- 52 Week Low
- XNCR $15.31
- CSTM $9.95
- 52 Week High
- XNCR $27.24
- CSTM $23.20
- Technical
- Relative Strength Index (RSI)
- XNCR 38.80
- CSTM 46.69
- Support Level
- XNCR $19.15
- CSTM $10.12
- Resistance Level
- XNCR $24.66
- CSTM $11.11
- Average True Range (ATR)
- XNCR 1.14
- CSTM 0.38
- MACD
- XNCR -0.37
- CSTM 0.11
- Stochastic Oscillator
- XNCR 24.96
- CSTM 57.33
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About CSTM Constellium SE (France)
Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: i) Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium products in European and North American facilities. ii) Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities. iii) The Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.